• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Johnson & Johnson

9 medical devices you should keep an eye out for in 2021

April 16, 2021 By Nancy Crotti Leave a Comment

The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021. Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek approval or […]

Filed Under: Business/Financial News, Diagnostics, Endoscopic, Featured, Food & Drug Administration (FDA), Imaging, Implants, Neuromodulation/Neurostimulation, Oncology, Optical/Ophthalmic, Orthopedics, Pain Management, Pediatrics, Robotics, Spine, Surgical, Vision Tagged With: DePuy Synthes, Johnson & Johnson, Medtronic, Nevro Corp., Olympus, OrthoPediatrics, Smith+Nephew, Zimmer Biomet

A quick history of the tech behind J&J, AstraZeneca’s COVID-19 vaccines

April 16, 2021 By Brian Buntz Leave a Comment

Regulatory authorities in the U.S. and Europe have either paused or constrained the use of COVID-19 vaccines from AstraZeneca (LON:AZN) and Johnson & Johnson (NYSE:JNJ), causing some to wonder why the adenoviral-vector vaccines have been potentially linked to similar blood clotting events. Researchers have observed blood clotting events associated with adenoviral vectors since the late-1990s […]

Filed Under: Featured, Pharmaceutical Tagged With: adenovirus vector, AstraZeneca, coronavirus, COVID-19, Johnson & Johnson

Vaccine panel postpones vote on J&J COVID-19 vaccine

April 14, 2021 By Brian Buntz Leave a Comment

A CDC advisory committee decided not to vote on how Johnson & Johnson’s COVID-19 vaccine should be deployed, reasoning that it needs more time to review data related to rare blood clots potentially linked to the vaccine. The CDC and FDA announced on April 13 their recommendation to pause the vaccine’s use on safety grounds. […]

Filed Under: Featured, Pharmaceutical Tagged With: ACIP, Advisory Committee on Immunization Practices, COVID-19, J&J, Johnson & Johnson

EU won’t renew J&J, AstraZeneca vaccine contracts, report says

April 14, 2021 By Sean Whooley Leave a Comment

Reports from Italy claim that the European Union Commission won’t renew COVID-19 vaccine contracts next year with AstraZeneca and Johnson & Johnson. According to Reuters, Italian outlet La Stampa reported that sources from the Italian health ministry have said the commission does not want to pursue contract renewals with those two companies once those encompassing the current year expire, […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Pharmaceutical Tagged With: AstraZeneca, BioNTech, coronavirus, COVID-19, COVID-19 vaccine, COVID-19 vaccines, Johnson & Johnson, Moderna, Pfizer

Pfizer to boost vaccine production for U.S. by 10%

April 14, 2021 By Nancy Crotti Leave a Comment

Pfizer will deliver 10% more of its COVID-19 vaccine to the U.S. by the end of May than originally planned, its CEO tweeted yesterday. The tweet follows the federal government’s decision to recommend a temporary halt in the distribution of Johnson & Johnson’s single-dose vaccine, which has been tied to rare instances of blood clot […]

Filed Under: Business/Financial News, Distribution, Featured Tagged With: CDC, coronavirus, COVID-19 vaccine, FDA, Johnson & Johnson, Pfizer

Feds halt J&J COVID-19 vaccine due to blood clot concern

April 13, 2021 By Sean Whooley Leave a Comment

The FDA and CDC issued a joint statement today recommending the pause in the administration of the Johnson & Johnson COVID-19 vaccine. As of yesterday, more than 6.8 million doses of the J&J single-dose vaccine had been administered in the U.S. Among recipients of those doses, six cases of a rare and severe type of blood […]

Filed Under: Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: CDC, Centers for Disease Control & Prevention (CDC), coronavirus, COVID-19, COVID-19 vaccine, FDA, Johnson & Johnson, U.S. Centers for Disease Control and Prevention (CDC)

J&J Vision, Menicon to collaborate on therapeutic contact lens

April 7, 2021 By Sean Whooley Leave a Comment

Johnson & Johnson (NYSE:JNJ) Vision announced today that it entered into a strategic collaboration with Menicon for contact lens development. J&J Vision and Menicon are partnering to bring forward a novel portfolio of products and services to manage the progression of myopia, sometimes known as “nearsightedness,” in children, according to a news release. Menicon is […]

Filed Under: Business/Financial News, Optical/Ophthalmic, Pediatrics Tagged With: Johnson & Johnson, Johnson & Johnson Vision

Emergent has reportedly had serious problems at Baltimore vaccine plant

April 6, 2021 By Chris Newmarker Leave a Comment

Emergent BioSolutions was not prepared to take on the mammoth task of churning out millions of COVID-19 vaccine doses to support U.S. efforts to end the pandemic, according to a report published today in The New York Times. Emergent was ill-equipped despite a $163 million federal contract to prepare the facility for high-volume production, according to the Times investigation, […]

Filed Under: Contract Manufacturing, Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, COVID-19 vaccine, Emergent BioSolutions, Johnson & Johnson

Feds put J&J in charge of vaccine production at Emergent plant

April 5, 2021 By Sean Whooley

Johnson & Johnson (NYSE:JNJ) announced that it assumed full responsibility for the production of its COVID-19 vaccine at the Emergent BioSolutions Bayview (Baltimore) facility. The company’s announcement comes days after news broke that a factory error made at that facility resulted in 15 million discarded COVID-19 vaccines. Get the full story at our sister site, […]

Filed Under: Contract Manufacturing, Featured, Food & Drug Administration (FDA), Pharmaceutical, Regulatory/Compliance Tagged With: coronavirus, COVID-19, Emergent BioSolutions, FDA, Johnson & Johnson

Whistleblower: FDA downplayed safety issues at Merck vaccine plant

April 2, 2021 By Brian Buntz

A former FDA inspector accused the agency of downplaying safety problems at a Merck plant tapped to manufacture Johnson & Johnson’s COVID-19 vaccine. The whistleblower alleged that a 2018 inspection uncovered evidence that employees in the facility in Durham, N.C.engaged in a host of unsanitary practices. A letter to President Biden from the U.S. Office […]

Filed Under: Featured, Pharmaceutical Tagged With: coronavirus, COVID-19, Johnson & Johnson, Merck

8 medical device companies that beat the COVID-19 pandemic and prospered

March 29, 2021 By Danielle Kirsh

Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread. Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was […]

Filed Under: Cardiac Implants, Cardiovascular, Catheters, Dental, Diagnostics, Endoscopic, Featured, Hospital Care, Imaging, Implants, Neuromodulation/Neurostimulation, Orthopedics, Replacement Heart Valves, Research & Development, Structural Heart Tagged With: 3m, Abbott, Alcon, Align Technology, Baxter, Big 100, Boston Scientific, coronavirus, COVID-19, danaher, Dentsply Sirona, Edwards Lifesciences, gehealthcare, Henry Schein, Intuitive Surgical, Johnson & Johnson, medline industries, Owens & Minor, Royal Philips, Smith+Nephew, Stryker, Teleflex, Zimmer Biomet

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 8
  • Go to Next Page »

Primary Sidebar

DeviceTalks by MassDevice · How Zimmer Biomet is competing in ortho’s data race; Do medical devices carry physics-based biases?

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS